Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

1.4K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.3K
Principles of Drug Action01:24

Principles of Drug Action

7.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
7.7K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

4.0K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stimuli-Responsive Chemical Systems That Mimic Biological Dynamics.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Bicaval TricValve Implantation in Patients With Severe Tricuspid Regurgitation: 1-Year Outcomes From the TricBicaval Registry.

JACC. Cardiovascular interventions·2025
Same author

Dynamic combinatorial chemistry directed by proteins and nucleic acids: a powerful tool for drug discovery.

Chemical Society reviews·2025
Same author

Nucleophilic catalysis of p-substituted aniline derivatives in acylhydrazone formation and exchange.

Organic & biomolecular chemistry·2021
Same author

Biomimetic selenocystine based dynamic combinatorial chemistry for thiol-disulfide exchange.

Nature communications·2021
Same author

Insights into real-time chemical processes in a calcium sensor protein-directed dynamic library.

Nature communications·2019

Related Experiment Video

Updated: Dec 3, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

891

Protein-Directed Dynamic Combinatorial Chemistry: An Efficient Strategy in Drug Design.

Andrea Canal-Martín1, Ruth Pérez-Fernández1

  • 1Structural and Chemical Biology Department, Centro de Investigaciones Biológicas "Margarita Salas", CIB-CSIC, Madrid 28040, Spain.

ACS Omega
|October 28, 2020
PubMed
Summary

Protein-directed dynamic combinatorial chemistry (P-DCC) identifies drug ligands by using proteins to select binding compounds from a dynamic library. This amplification process discovers new hit compounds for therapeutic targets.

More Related Videos

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

8.1K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.7K

Related Experiment Videos

Last Updated: Dec 3, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

891
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

8.1K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.7K

Area of Science:

  • Medicinal Chemistry
  • Chemical Biology
  • Drug Discovery

Background:

  • Protein-directed dynamic combinatorial chemistry (P-DCC) is a powerful method for identifying ligands for protein targets.
  • This technique leverages a protein's ability to thermodynamically template ligand binding.
  • Ligand binding shifts library composition, amplifying desired affinity molecules.

Purpose of the Study:

  • To provide an updated overview of protein-directed DCC applications.
  • To discuss fundamental aspects of designing P-DCC experiments.
  • To highlight suitable reversible reactions and analytical methodologies.

Main Methods:

  • Review of existing literature on P-DCC.
  • Analysis of thermodynamic templating effects in ligand discovery.
  • Discussion of biocompatible reversible reactions for library synthesis.
  • Examination of experimental analysis techniques for P-DCC.

Main Results:

  • P-DCC effectively identifies high-affinity ligands for various protein targets.
  • The amplification of selected library members is key to hit compound discovery.
  • Biocompatible reversible reactions and appropriate analytical methods are crucial for successful P-DCC experiments.

Conclusions:

  • Protein-directed DCC is a valuable strategy for discovering novel ligands and drug candidates.
  • Careful consideration of reaction chemistry and experimental design enhances P-DCC efficiency.
  • This approach accelerates the identification of pharmacologically relevant compounds.